Data as of Nov 25
| +0.22 / +0.42%|
The 21 analysts offering 12-month price forecasts for ResMed Inc have a median target of 52.79, with a high estimate of 66.51 and a low estimate of 40.00. The median estimate represents a -0.50% decrease from the last price of 53.05.
The current consensus among 24 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.